Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nppv-respiratory-failure_research-protocol.pdf
    April 21, 2011 - events, or lower medical utilization: a. … events outcomes). … The safety outcomes will be framed to help identify adverse events, including aspiration, secondary … events; and intermediate, final, and adverse events outcomes. … intervention-group rates of events, or both.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
    August 01, 2012 - Events: The incidence of other adverse events i.e. dermatitis 7 and dysphagia 6 favored IMRT treatment … The original CER reported inconsistent results for other adverse events. … events. … Similarly inconsistent results for adverse events were found in the original CER 1 signal (A1) … events.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - Among other adverse events, beta blockers may be associated with depression, possible exacerbation of … Based on these known adverse events the conclusion that beta blockers are without bothersome harms … events, compared with 10% of the 445 placebo‐treated patients. … Most topiramate‐associated adverse events were mild or moderate in severity, and they occurred more … We analyzed specific safety outcome (specific adverse effects or treatment discontinuation due to adverse
  4. Gout Executive-2016 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
    January 01, 2016 - events (including adverse patient experiences such as pain or infection at the aspiration site, effects … events, were included if they addressed Key Question 2 (adverse events or other negative outcomes … tests used to diagnose gout.28 This study reported no adverse events associated with aspiration of … No studies were identified that documented any adverse events associated with diagnostic tests included … Events Adverse events associated with procedures US Insufficient No conclusion possible DECT Low Evidence
  5. effectivehealthcare.ahrq.gov/sites/default/files/cer-224-depression-children-comments.pdf
    April 10, 2020 - Therefore, it is not clear how serious adverse events are defined or qualified for the purpose of the … If the serious adverse events aren’t defined by industry standards, AACAP recommends that the term … Public reviewer: AACAP Measure- ment of Adverse Outcomes/ Events The Review brings attention … Some terms are not well-defined such as “mixed depressive disorders” and “serious adverse events”. … We also added text to methods section on “serious adverse events.”
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
    April 10, 2020 - Therefore, it is not clear how serious adverse events are defined or qualified for the purpose of the … If the serious adverse events aren’t defined by industry standards, AACAP recommends that the term … Public reviewer: AACAP Measure- ment of Adverse Outcomes/ Events The Review brings attention … Some terms are not well-defined such as “mixed depressive disorders” and “serious adverse events”. … We also added text to methods section on “serious adverse events.”
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
    September 22, 2011 - events. … Nonadherence to HCV treatment may be associated with a lack of management of adverse events,5,10 higher … events. … Although neither study found adverse events associated with the use of epoetin or citalopram, both … Both studies reported that no patients showed adverse events related to the use of these medications
  8. effectivehealthcare.ahrq.gov/system/files/cer-233-diverticulitis-evidence-summary.pdf
    October 01, 2020 - Adverse outcomes, such as mortality and emergency surgery are uncommon (3% of patients or fewer), regardless … Evidence regarding dDeath, treatment failure, diverticulitis-related morbidities, rehospitalization, and adverseevents are mostly rare and evidence is insufficient to make conclusions. … These events are mostly rare. … There was low to moderate SoE that serious adverse events are uncommon with elective surgery, including
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
    October 01, 2020 - Adverse outcomes, such as mortality and emergency surgery are uncommon (3% of patients or fewer), regardless … Evidence regarding dDeath, treatment failure, diverticulitis-related morbidities, rehospitalization, and adverseevents are mostly rare and evidence is insufficient to make conclusions. … These events are mostly rare. … There was low to moderate SoE that serious adverse events are uncommon with elective surgery, including
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
    June 24, 2014 - blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular events … What adverse events and complications have been associated with aggressive medical therapy or renal
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
    November 22, 2011 - cardiovascular events. … cardiovascular events; however they reached contradictory conclusions. … effects of test-directed treatment (including bleeding events and other adverse events such as gastrointestinal … events and liver toxicity) o Adverse effects of testing per se (including test-related anxiety and … adverse events secondary to venipuncture)
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
    October 01, 2012 - • Health outcomes, such as morbidity, mortality, function, quality of life, and adverse events of … events of therapy). … events. … adverse reactions were lacking. … Events?
  13. effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine/research-protocol
    December 06, 2010 - Many questions remain about the risks of these agents across a spectrum of adverse events—from relatively … KQ4: Physical functioning Quality of life KQ3 and KQ4: Morbidity, mortality, and other serious adverseevents Tolerability Adherence Other adverse effects Timing: Minimum of 3 months of follow-up … Also, adverse events may occur at any point after the treatment is received. Methods A. … as measured by HAQ, SF36 Health Survey, etc), quality of life KQ3: harms, tolerability, adherence, adverse
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
    December 06, 2010 - Many questions remain about the risks of these agents across a spectrum of adverse events from relatively … Like in RA trials, many questions remain about the risks of these agents across a spectrum of adverseevents from relatively minor side effects such as injection site reactions to severe and possibly … Morbidity, mortality and other serious adverse events ii. … Also, adverse events may occur at any point after the treatment is received. IV. Methods A.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
    December 20, 2012 - We agree that interventions for managing adverse events may be considered patient- level interventions … effects” “adverse events”, or “side effects.” … We have replaced adverse effects with “adverse events” throughout the document. … We agree that interventions for managing adverse events may be considered patient- level interventions … We agree that interventions for managing adverse events may be considered patient- level interventions
  16. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - No significant adverse events were reported. … No serious adverse events or withdrawal due to adverse events were reported. … No serious adverse events were observed. … No serious adverse events, death, and withdrawal due to adverse events were reported. … No patients reported adverse events.
  17. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - No significant adverse events were reported. … No serious adverse events or withdrawal due to adverse events were reported. … No serious adverse events were observed. … No serious adverse events, death, and withdrawal due to adverse events were reported. … No patients reported adverse events.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - Intranasal corticosteroids do not appear to cause adverse events associated with systemic absorption … Adverse events may occur at any point after treatment is received and may impact quality of life directly … Meta- analysis was performed for adverse events that investigators reported as severe or that led to … events are not expected. … events; underrepresentation of populations of interest, especially children and pregnant women; and
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
    January 01, 2020 - What adverse events are collected in clinical studies (Phases I–IV) and in observational studies containing … Our results support most findings of the IOM report, add conclusions on some adverse events for which … Broad categories such as “injection-related adverse events,” “systemic adverse events,” “one or more … adverse events,” or “serious adverse events” were reported rather than specific AEs. … Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. May 28, 2009. 19.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
    November 27, 2012 - This is in contrast to Telaprevir’s association with dermatological adverse events, which are unique … We have have made distinctions in our report regarding the adverse events for each drug. … This false impression is further reinforced by the consistent pairing of hematological adverse events … Page 69: "… specific harms associated with use of these drugs (such as hematologic adverse events with … boceprevir…" As noted on pages 46 and 47 of this review, hematologic adverse events are not specific

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: